Flagship startup Serif says it has solved non-viral gene therapy in monkeys

Serif Biomedicines scientist Rob Fletcher evaluates modified DNA using fast protein liquid chromatography. Credit: Serif Biomedicines May 12, 2026 06:00 AM EDT R&DCell/Gene Tx Flag­ship start­up says it has solved non-vi­ral gene ther­a­py in mon­keys, but de­tails re­main murky Ryan Cross Senior Science Correspondent BOSTON — Serif Bio­med­i­cines, a start­up launched last month by Flag­ship Pi­o­neer­ing, be­lieves it has solved two tech­ni­cal chal­lenges that have long pre­vent­ed … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER